Cargando…
Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325752/ https://www.ncbi.nlm.nih.gov/pubmed/36806245 http://dx.doi.org/10.1097/CM9.0000000000002270 |
_version_ | 1785069288165474304 |
---|---|
author | Bao, Pengtao Gong, Jiuyu Mu, Mi Que, Yifan Hu, Peng Luo, Jiang Chang, Christopher Xu, Guogang |
author_facet | Bao, Pengtao Gong, Jiuyu Mu, Mi Que, Yifan Hu, Peng Luo, Jiang Chang, Christopher Xu, Guogang |
author_sort | Bao, Pengtao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10325752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103257522023-07-07 Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity Bao, Pengtao Gong, Jiuyu Mu, Mi Que, Yifan Hu, Peng Luo, Jiang Chang, Christopher Xu, Guogang Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-07-05 2023-02-13 /pmc/articles/PMC10325752/ /pubmed/36806245 http://dx.doi.org/10.1097/CM9.0000000000002270 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Correspondence Bao, Pengtao Gong, Jiuyu Mu, Mi Que, Yifan Hu, Peng Luo, Jiang Chang, Christopher Xu, Guogang Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
title | Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
title_full | Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
title_fullStr | Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
title_full_unstemmed | Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
title_short | Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
title_sort | coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325752/ https://www.ncbi.nlm.nih.gov/pubmed/36806245 http://dx.doi.org/10.1097/CM9.0000000000002270 |
work_keys_str_mv | AT baopengtao coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT gongjiuyu coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT mumi coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT queyifan coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT hupeng coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT luojiang coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT changchristopher coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity AT xuguogang coronavirusdisease2019vaccineschallengesofusingglobalmassvaccinationtoachieveherdimmunity |